Silencing ANXA3 suppresses the NFκB pathway via upregulating IκBα, leading to mesenchymal-epithelial transition (MET) with attenuated invasion and metastasis, but promotes tumor cell proliferation. The gene discussed is ANXA3; the disease is neoplasm.